Goldman Sachs Group Inc Avid Bioservices, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,951,297 shares of CDMO stock, worth $24.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,951,297
Previous 475,411 310.44%
Holding current value
$24.4 Million
Previous $5.41 Million 345.43%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$9.96 - $12.36 $14.7 Million - $18.2 Million
1,475,886 Added 310.44%
1,951,297 $24.1 Million
Q3 2024

Nov 14, 2024
SELL
$6.7 - $12.45 $1.6 Million - $2.98 Million
-239,257 Reduced 33.48%
475,411 $5.41 Million
Q2 2024

Aug 13, 2024
SELL
$6.34 - $9.28 $1.3 Million - $1.91 Million
-205,433 Reduced 22.33%
714,668 $5.1 Million
Q1 2024

May 15, 2024
BUY
$5.86 - $8.79 $1.66 Million - $2.5 Million
283,922 Added 44.63%
920,101 $6.16 Million
Q4 2023

Feb 13, 2024
BUY
$4.64 - $9.56 $1.61 Million - $3.31 Million
346,153 Added 119.35%
636,179 $4.14 Million
Q3 2023

May 14, 2024
SELL
$9.4 - $14.04 $3.25 Million - $4.86 Million
-346,153 Reduced 54.41%
290,026 $2.74 Million
Q3 2023

Nov 14, 2023
SELL
$9.4 - $14.04 $830,443 - $1.24 Million
-88,345 Reduced 23.35%
290,026 $2.74 Million
Q2 2023

May 14, 2024
SELL
$12.96 - $20.93 $474,478 - $766,268
-36,611 Reduced 8.82%
378,371 $5.29 Million
Q2 2023

Aug 14, 2023
SELL
$12.96 - $20.93 $474,478 - $766,268
-36,611 Reduced 8.82%
378,371 $5.29 Million
Q1 2023

May 14, 2024
SELL
$13.48 - $18.79 $469,387 - $654,286
-34,821 Reduced 7.74%
414,982 $7.79 Million
Q1 2023

May 11, 2023
SELL
$13.48 - $18.79 $469,387 - $654,286
-34,821 Reduced 7.74%
414,982 $7.79 Million
Q4 2022

May 14, 2024
BUY
$12.61 - $18.74 $703,612 - $1.05 Million
55,798 Added 14.16%
449,803 $6.19 Million
Q4 2022

Feb 13, 2023
BUY
$12.61 - $18.74 $703,612 - $1.05 Million
55,798 Added 14.16%
449,803 $6.19 Million
Q3 2022

May 14, 2024
BUY
$15.33 - $20.36 $675,577 - $897,244
44,069 Added 12.59%
394,005 $7.53 Million
Q3 2022

Nov 10, 2022
BUY
$15.33 - $20.36 $675,577 - $897,244
44,069 Added 12.59%
394,005 $7.53 Million
Q2 2022

May 14, 2024
SELL
$11.63 - $21.55 $3.33 Million - $6.17 Million
-286,243 Reduced 44.99%
349,936 $5.34 Million
Q2 2022

Aug 15, 2022
SELL
$11.63 - $21.55 $765,242 - $1.42 Million
-65,799 Reduced 15.83%
349,936 $5.34 Million
Q1 2022

May 16, 2022
SELL
$16.63 - $27.73 $1.93 Million - $3.22 Million
-116,041 Reduced 21.82%
415,735 $8.47 Million
Q4 2021

Feb 14, 2022
SELL
$20.7 - $34.18 $5.55 Million - $9.16 Million
-268,051 Reduced 33.51%
531,776 $15.5 Million
Q3 2021

Nov 10, 2021
BUY
$19.05 - $28.32 $15.2 Million - $22.7 Million
799,827 New
799,827 $17.3 Million

Others Institutions Holding CDMO

# of Institutions
209
Shares Held
67.1M
Call Options Held
216K
Put Options Held
4.6K
View Full List

About Avid Bioservices, Inc.

CDMO Quotes by TradingView
  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email